Author： Swanberg M.M.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.25, Iss.7, 2002-01, pp. : 511-523
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Treatment of Dementia with Lewy Bodies and Parkinson's Disease Dementia
Drugs & Aging, Vol. 28, Iss. 10, 2011-10 ,pp. :
Access to resources
Recommend
Dementia with Lewy Bodies: Clinical Features and Treatment
By Campbell S. Stephens S. Ballard C.
Drugs & Aging, Vol. 18, Iss. 6, 2001-06 ,pp. :
Pharmacotherapy of dementia with Lewy bodies
By Fernandez Hubert H Wu Chuang-Kuo Ott Brian R
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. :
Rivastigmine beneficial in dementia with Lewy bodies
Inpharma, Vol. 1, Iss. 1269, 2001-01 ,pp. :
Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer
Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. :